Literature DB >> 16458770

Compulsory vaccination and conscientious or philosophical exemptions: past, present, and future.

Daniel A Salmon1, Stephen P Teret, C Raina MacIntyre, David Salisbury, Margaret A Burgess, Neal A Halsey.   

Abstract

Compulsory vaccination has contributed to the success of immunisation programmes in the USA and Australia, yet the benefits from compulsory vaccination are not universally recognised. Some people--experts and the public alike--believe that the benefits of compulsory vaccination are outweighed by the associated ethical problems. A review of vaccination legislation in the UK, Australia, and the USA raises four main points. First, compulsory vaccination may be effective in preventing disease outbreaks, reaching and sustaining high immunisation coverage rates, and expediting the introduction of new vaccines. Second, to be effective, compulsory programmes must have a reliable supply of safe and effective vaccines and most people must be willing to be vaccinated. Third, allowance of exemptions to compulsory vaccination may limit public backlash. Finally, compulsory vaccination may increase the burden on governments to ensure the safety of vaccines. Nevertheless, although compulsory immunisation can be very effective, it might not be acceptable in some countries where high coverage has been achieved through other approaches or efforts, such as in Sweden, Norway, Denmark, the Netherlands, and the UK. These factors should be considered when compulsory vaccinations are being introduced or immunisation laws refined. Lessons learned from compulsory vaccination could be useful to other public-health programmes.

Entities:  

Keywords:  Analytical Approach; Health Care and Public Health

Mesh:

Year:  2006        PMID: 16458770     DOI: 10.1016/S0140-6736(06)68144-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  45 in total

1.  An intensive 5-year-long influenza vaccination campaign is effective among doctors but not nurses.

Authors:  A Friedl; C Aegerter; E Saner; D Meier; J H Beer
Journal:  Infection       Date:  2011-09-29       Impact factor: 3.553

Review 2.  Identifying and addressing vaccine hesitancy.

Authors:  Lori A Kestenbaum; Kristen A Feemster
Journal:  Pediatr Ann       Date:  2015-04       Impact factor: 1.132

3.  Immunity for the people: the challenge of achieving high vaccine coverage in American history.

Authors:  James Colgrove
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

4.  Vaccinating in disease-free regions: a vaccine model with application to yellow fever.

Authors:  Claudia T Codeço; Paula M Luz; Flavio Coelho; Alison P Galvani; Claudio Struchiner
Journal:  J R Soc Interface       Date:  2007-12-22       Impact factor: 4.118

5.  Global eradication of polio: the case for "finishing the job".

Authors:  Chandrakant Lahariya
Journal:  Bull World Health Organ       Date:  2007-06       Impact factor: 9.408

6.  Improving uptake of MMR vaccine.

Authors:  Peter McIntyre; Julie Leask
Journal:  BMJ       Date:  2008-02-28

7.  Exploring California's new law eliminating personal belief exemptions to childhood vaccines and vaccine decision-making among homeschooling mothers in California.

Authors:  Pamela McDonald; Rupali J Limaye; Saad B Omer; Alison M Buttenheim; Salini Mohanty; Nicola P Klein; Daniel A Salmon
Journal:  Vaccine       Date:  2019-01-06       Impact factor: 3.641

8.  Compulsory school-entry vaccination laws and exemptions: who is opting out in ontario and why does it matter?

Authors:  Catherine L Mah; Astrid Guttmann; Allison McGeer; Murray Krahn; Raisa B Deber
Journal:  Healthc Policy       Date:  2010-05

9.  Are we ready to abrogate compulsory vaccinations for children?

Authors:  Domenico Martinelli; Silvio Tafuri; Francesca Fortunato; Vanessa Cozza; Cinzia A Germinario; Rosa Prato
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

10.  Dynamic modeling of vaccinating behavior as a function of individual beliefs.

Authors:  Flávio Codeço Coelho; Claudia T Codeço
Journal:  PLoS Comput Biol       Date:  2009-07-10       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.